Lorvotuzumab

CAT: 0804-HY-P99372-01Size: 1 mgDry Ice: YesHazardous: No
CAT#:0804-HY-P99372-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab) ) is a humanized monoclonal antibody that binds CD56 (NCAM1) . Lorvotuzumab can be used to synthesize an ADC compound, Lorvotuzumab mertansine[1].
CAS Number
[339306-30-8]
Product Name Alternative
Anti-NCAM1/ CD56 Reference Antibody (lorvotuzumab)
UNSPSC
12352203
Target
ADC Antibody
Type
Inhibitory Antibodies
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/lorvotuzumab.html
Purity
99.77
Solubility
10 mM in DMSO
Smiles
[Lorvotuzumab]
Molecular Weight
(146.44 kDa)
References & Citations
[1]James I Geller, et al. ADVL1522: A phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma-A Children's Oncology Group study. Cancer. 2020 Dec 15;126 (24) :5303-5310.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Related Products

CatalogName

Alternative Products

CatalogName
M36882-01Lorvotuzumab
T9901A-032-01Lorvotuzumab mertansine
T9901A-205-01Lorvotuzumab MMAE
DHC98598Lorvotuzumab-MMAE (ADC)
KET-10687Lorvotuzumab ELISA Kit
DHC98599Lorvotuzumab mertansine (ADC)
E55B0357Lorvotuzumab (Reference antibody)
DHC98501Research Grade Lorvotuzumab
048334NCAM1/CD56 (lorvotuzumab) discontinued
C00201-01Lorvotuzumab (Anti-NCAM1 / CD56)

Popular Products